EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

Kyriakie Sarafoglou, Mimi S Kim, Maya Lodish, Eric I Felner, Laetitia Martinerie, Natalie J Nokoff, María Clemente, Patricia Y Fechner, Maria G Vogiatzi, Phyllis W Speiser, Richard J Auchus, Gelliza B G Rosales und 5 weitere

New England Journal of Medicine · 2024

DOI: 10.1056/nejmoa2404655 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Kyriakie Sarafoglou und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the University of Minnesota Medical School and College of Pharmacy, Minneapolis (K.S.); Children's Hospital Los Angeles and Keck School of Medic…. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Androstenedione, Glucocorticoids, Amines. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NIDDK NIH HHS, Neurocrine Biosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalAndrostenedioneGlucocorticoidsAminesThiazolesAdolescentChildChild, PreschoolFemaleHumansMaleDouble-Blind MethodHydrocortisoneReceptors, Corticotropin-Releasing HormoneHeadacheFeverVomitingCRF Receptor, Type 1

Substanzen

AndrostenedioneGlucocorticoidsHydrocortisonecrinecerfontAminesThiazolesCRF Receptor, Type 1Receptors, Corticotropin-Releasing Hormone

Autor:innen und Institutionen

  • From the University of Minnesota Medical School and College of Pharmacy, Minneapolis (K.S.); Children's Hospital Los Angeles and Keck School of Medicine of USC, Los Angeles (M.S.K.), the University of California at San…

Förderung

  • NIDDK NIH HHS
  • Neurocrine Biosciences

Zitieren

APA

Sarafoglou, K., Kim, M. S., Lodish, M., Felner, E. I., Martinerie, L., Nokoff, N. J., Clemente, M., Fechner, P. Y., Vogiatzi, M. G., Speiser, P. W., Auchus, R. J., Rosales, G. B. G., Roberts, E., Jeha, G. S., Farber, R. H., Chan, J. L., & CAHtalyst Pediatric Trial Investigators (2024). Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2404655

Vancouver

Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, et al. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia. New England Journal of Medicine. 2024. doi:10.1056/nejmoa2404655

BibTeX
@article{Sarafoglou2024,
  author = {Sarafoglou, Kyriakie and Kim, Mimi S and Lodish, Maya and Felner, Eric I and Martinerie, Laetitia and Nokoff, Natalie J and Clemente, María and Fechner, Patricia Y and Vogiatzi, Maria G and Speiser, Phyllis W and Auchus, Richard J and Rosales, Gelliza B G and Roberts, Eiry and Jeha, George S and Farber, Robert H and Chan, Jean L and CAHtalyst Pediatric Trial Investigators, CAHtalyst Pediatric Trial Investigators},
  title = {Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmoa2404655}
}
Kostenlos starten →